Cargando…

Corrigendum: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Bisceglia, Irma, Canale, Maria Laura, Gallucci, Giuseppina, Turazza, Fabio Maria, Lestuzzi, Chiara, Parrini, Iris, Russo, Giulia, Maurea, Nicola, Quagliariello, Vincenzo, Oliva, Stefano, Di Fusco, Stefania Angela, Lucà, Fabiana, Tarantini, Luigi, Trambaiolo, Paolo, Moreo, Antonella, Geraci, Giovanna, Gabrielli, Domenico, Gulizia, Michele Massimo, Oliva, Fabrizio, Colivicchi, Furio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136444/ https://www.ncbi.nlm.nih.gov/pubmed/35647054 http://dx.doi.org/10.3389/fcvm.2022.903766

Ejemplares similares

Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story
por: Bisceglia, Irma, et al.
Publicado: (2022)

Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story
por: Bisceglia, Irma, et al.
Publicado: (2023)

ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)
por: Bisceglia, Irma, et al.
Publicado: (2021)

Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey
por: Canale, Maria Laura, et al.
Publicado: (2021)

Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey
por: Canale, Maria Laura, et al.
Publicado: (2022)

Women at heart: Introducing gender cardio-oncology
por: Canale, Maria Laura, et al.
Publicado: (2022)

Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals
por: Bisceglia, Irma, et al.
Publicado: (2023)

Corrigendum: Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals
por: Bisceglia, Irma, et al.
Publicado: (2023)

Screening and management of dyslipidemia in oncologic patients undergoing cardiotoxic therapies: results from an Italian survey
por: Camilli, Massimiliano, et al.
Publicado: (2023)

ANMCO/AIOM/AICO Consensus Document on clinical and management pathways of cardio-oncology: executive summary
por: Tarantini, Luigi, et al.
Publicado: (2017)

Impact of Working from Home on Cardiovascular Health: An Emerging Issue with the COVID-19 Pandemic
por: Di Fusco, Stefania Angela, et al.
Publicado: (2021)

Italian Association of Hospital Cardiologists practical guidance for sodium–glucose cotransporter 2 inhibitors use in patients with heart failure
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

Management of Acute Coronary Syndrome in Cancer Patients: It’s High Time We Dealt with It
por: Lucà, Fabiana, et al.
Publicado: (2022)

Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy
por: Canale, Maria Laura, et al.
Publicado: (2020)

PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology
por: Quagliariello, Vincenzo, et al.
Publicado: (2023)

The role of the pregnancy heart team in clinical practice
por: Lucà, Fabiana, et al.
Publicado: (2023)

Incidence, Characteristics, and Management of Patients with Recurrent Myocardial Infarctions: Insights from the EYESHOT POST-MI
por: De Luca, Leonardo, et al.
Publicado: (2022)

Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START Study
por: De Luca, Leonardo, et al.
Publicado: (2022)

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios
por: Lucà, Fabiana, et al.
Publicado: (2023)

Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management
por: Lucà, Fabiana, et al.
Publicado: (2023)

Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO)
por: Mocini, David, et al.
Publicado: (2021)

ANMCO position paper: 2022 focused update of appropriate use criteria for multimodality imaging: aortic valve disease
por: Nardi, Federico, et al.
Publicado: (2022)

ANMCO POSITION PAPER: Use of sacubitril/valsartan in hospitalized patients with acute heart failure
por: Di Tano, Giuseppe, et al.
Publicado: (2021)

Clinical Utility of Three-Dimensional Echocardiography in the Evaluation of Mitral Valve Disease: Tips and Tricks
por: Pino, Paolo G., et al.
Publicado: (2023)

Case Series: Recovery of Chemotherapy-Related Acute Heart Failure by the Combined Use of Sacubitril Valsartan and Wearable Cardioverter Defibrillator: A Novel Winning Combination in Cardio-Oncology
por: Canale, Maria Laura, et al.
Publicado: (2022)

Cardiologic Long-Term Follow-Up of Patients Treated With Chest Radiotherapy: When and How?
por: Lestuzzi, Chiara, et al.
Publicado: (2021)

Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways
por: Quagliariello, Vincenzo, et al.
Publicado: (2022)

Corrigendum: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways
por: Quagliariello, Vincenzo, et al.
Publicado: (2023)

ANMCO position paper on vericiguat use in heart failure: from evidence to place in therapy
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

COVID-19, Vaccines, and Thrombotic Events: A Narrative Review
por: Abrignani, Maurizio G., et al.
Publicado: (2022)

Current Data and Future Perspectives on Patients with Atrial Fibrillation and Cancer
por: De Luca, Leonardo, et al.
Publicado: (2023)

ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation
por: Di Fusco, Stefania Angela, et al.
Publicado: (2022)

Type of hospitalisations and in-hospital outcomes in the Italian coronary care unit network at the time of COVID-19 pandemic: the BLITZ-COVID19 Registry
por: Gulizia, Michele Massimo, et al.
Publicado: (2022)

ANMCO-SIMEU consensus document: appropriate management of atrial fibrillation in the emergency department
por: Caldarola, Pasquale, et al.
Publicado: (2023)

Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing myocardial revascularization procedures
por: Caporale, Roberto, et al.
Publicado: (2017)

Spotlight on Italian Association of Hospital Cardiologists (ANMCO) activity in the 2–year period 2021–2023
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives
por: Nardi, Federico, et al.
Publicado: (2017)

Reply to Kielb et al. Untapped Potential for Female Patients? Comment on “Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176”
por: Lucà, Fabiana, et al.
Publicado: (2022)

ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death
por: Casolo, Giancarlo, et al.
Publicado: (2023)

Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes
por: Parrini, Iris, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_edfkvdcl00maip2nbfc2jdj15t